We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX
2851
DELISTED
Inhibrx, Inc. Common Stock
INBX
$52K ﹤0.01%
4,538
+3,178
+234% +$46.8K
ALNT icon
2852
Allient
ALNT
$1.93B
$51K ﹤0.01%
2,223
-4,709
-68% -$116K
BKD icon
2853
Brookdale Senior Living
BKD
$3.02B
$51K ﹤0.01%
11,201
+6,639
+146% +$39.2K
CELU icon
2854
Celularity
CELU
$20.6M
$51K ﹤0.01%
1,509
+1,219
+420% +$99K
CWBC
2855
Community West Bancshares
CWBC
$691M
$51K ﹤0.01%
+3,470
New +$63.6K
EIDO icon
2856
iShares MSCI Indonesia ETF
EIDO
$484M
$51K ﹤0.01%
2,261
+1,724
+321% +$41.5K
FBK icon
2857
FB Financial Corp
FBK
$3.08B
$51K ﹤0.01%
1,300
+1,018
+361% +$41K
FLNG icon
2858
FLEX LNG
FLNG
$1.59B
$51K ﹤0.01%
1,869
+1,668
+830% +$46.7K
GOVX icon
2859
GeoVax Labs
GOVX
$4.27M
$51K ﹤0.01%
164
+148
+925% +$65.2K
IGIB icon
2860
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$51K ﹤0.01%
1,000
+817
+446% +$42.6K
LYEL icon
2861
Lyell Immunopharma
LYEL
$375M
$51K ﹤0.01%
396
-37
-9% -$3.78K
NRDY icon
2862
Nerdy
NRDY
$94.9M
$51K ﹤0.01%
23,985
+19,870
+483% +$64.7K
PASG icon
2863
Passage Bio
PASG
$14.5M
$51K ﹤0.01%
1,096
+320
+41% +$14.9K
PHI icon
2864
PLDT
PHI
$4.2B
$51K ﹤0.01%
+1,674
New +$59.5K
PI icon
2865
Impinj
PI
$5.37B
$51K ﹤0.01%
863
+617
+251% +$31K
SLGC
2866
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$51K ﹤0.01%
11,339
+7,120
+169% +$42.4K
WE
2867
DELISTED
WeWork Inc.
WE
$51K ﹤0.01%
255
+116
+83% +$29.9K
MNRL
2868
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$51K ﹤0.01%
2,064
+181
+10% +$4.99K
ADAP
2869
DELISTED
Adaptimmune Therapeutics
ADAP
$50K ﹤0.01%
29,384
+24,671
+523% +$42.4K
AFMD
2870
DELISTED
Affimed
AFMD
$50K ﹤0.01%
1,815
+1,024
+129% +$35.1K
AXSM icon
2871
Axsome Therapeutics
AXSM
$11.2B
$50K ﹤0.01%
1,296
+816
+170% +$25.8K
BLBD icon
2872
Blue Bird Corp
BLBD
$2.1B
$50K ﹤0.01%
5,460
+5,328
+4,036% +$74.7K
CHEF icon
2873
Chefs' Warehouse
CHEF
$4.48B
$50K ﹤0.01%
1,279
+895
+233% +$31.4K
DEA
2874
Easterly Government Properties
DEA
$1.14B
$50K ﹤0.01%
1,070
-4,576
-81% -$223K
DOLE icon
2875
Dole
DOLE
$1.23B
$50K ﹤0.01%
5,923
+3,384
+133% +$37.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.